See commonly discussed GLP-1 options, then complete a clinician-guided health evaluation. We pair appropriate prescription care with nutrition, movement and ongoing support.
These products are shown for education and treatment discussion. They are not an online shelf. Eligibility, indication, dose, supply and final prescribing decisions belong to a licensed clinician.
A once-daily oral maintenance option for eligible adults. Treatment starts at a lower dose and is gradually increased under clinician direction.
A once-weekly prescription injection for chronic weight management in eligible patients.
A once-weekly prescription treatment for chronic weight management in eligible adults.
Approved for adults with type 2 diabetes. Its indication differs from Wegovy, so diagnosis and clinician judgment matter.
Approved to improve blood sugar control in eligible adults with type 2 diabetes. Its indication differs from Zepbound.
Review weight history, medical conditions, medications, goals and potential contraindications.
A licensed clinician determines whether a prescription option is medically appropriate.
Healthy eating guidance and low-, moderate- or higher-intensity exercise pathways support the plan.
Track progress, tolerability, strength and health—not only the number on the scale.
Prescription is not guaranteed. A licensed clinician must evaluate eligibility, indication, health history, contraindications and potential interactions.
Do not combine GLP-1 products. Patients should not use semaglutide-containing products together or take more than prescribed. Individual product warnings and instructions apply.
Images are educational. Product appearance, packaging and availability may change. The tablet artwork is a clear product-style illustration, not a dispensing photograph or actual-size representation.
Healthy weight management remains comprehensive. Medication is used with reduced-calorie nutrition, appropriate physical activity and longitudinal medical support.
Start my health assessment →